BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 16046395)

  • 41. Pharmacogenomics of the human µ-opioid receptor.
    Kasai S; Ikeda K
    Pharmacogenomics; 2011 Sep; 12(9):1305-20. PubMed ID: 21919606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor: a meta-analysis.
    Song Z; Du B; Wang K; Shi X
    Genet Test Mol Biomarkers; 2013 Oct; 17(10):743-9. PubMed ID: 23909491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel tetra-primer ARMS-PCR for genotyping of the OPRM1 gene rs1799971 variant associated with opioid use disorders.
    Wijekumar PJ; Ranadeva NDK; Jayamaha AR; Herath HMNDM; Noorden N; Fernando SSN
    BMC Res Notes; 2023 Nov; 16(1):333. PubMed ID: 37964305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.
    Bunten H; Liang WJ; Pounder DJ; Seneviratne C; Osselton D
    Clin Pharmacol Ther; 2010 Sep; 88(3):383-9. PubMed ID: 20668445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
    Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
    Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
    Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
    Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single nucleotide polymorphism in
    Koijam AS; Chakraborty B; Mukhopadhyay K; Rajamma U; Haobam R
    J Addict Dis; 2020; 38(2):214-222. PubMed ID: 32189578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration.
    Zhang Y; Collins D; Butelman ER; Blendy JA; Kreek MJ
    Neuropharmacology; 2020 Dec; 181():108351. PubMed ID: 33031806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations among the opioid receptor gene (
    Kim KM; Choi SW; Kim D; Lee J; Kim JW
    J Behav Addict; 2019 Sep; 8(3):463-470. PubMed ID: 31553235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mu opioid receptor gene variants: lack of association with alcohol dependence.
    Bergen AW; Kokoszka J; Peterson R; Long JC; Virkkunen M; Linnoila M; Goldman D
    Mol Psychiatry; 1997; 2(6):490-4. PubMed ID: 9399694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect.
    Misailidis G; Ragia G; Ivanova DD; Tavridou A; Manolopoulos VG
    Drug Metab Pers Ther; 2015 Jun; 30(2):129-35. PubMed ID: 25941919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
    Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
    Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced expression of the μ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G.
    Wang YJ; Huang P; Ung A; Blendy JA; Liu-Chen LY
    Neuroscience; 2012 Mar; 205():178-84. PubMed ID: 22240251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat.
    Briand LA; Hilario M; Dow HC; Brodkin ES; Blendy JA; Berton O
    J Neurosci; 2015 Feb; 35(8):3582-90. PubMed ID: 25716856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overview of Genetic Analysis of Human Opioid Receptors.
    Spampinato SM
    Methods Mol Biol; 2021; 2201():3-13. PubMed ID: 32975784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Relevance of the OPRM1 118A>G Genetic Variant for Opioid Requirement in Pain Treatment: A Meta-Analysis.
    Zhang X; Liang Y; Zhang N; Yan Y; Liu S; Fengxi H; Zhao D; Chu H
    Pain Physician; 2019 Jul; 22(4):331-340. PubMed ID: 31337162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction.
    LaForge KS; Shick V; Spangler R; Proudnikov D; Yuferov V; Lysov Y; Mirzabekov A; Kreek MJ
    Am J Med Genet; 2000 Oct; 96(5):604-15. PubMed ID: 11054767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis.
    Glatt SJ; Bousman C; Wang RS; Murthy KK; Rana BK; Lasky-Su JA; Zhu SC; Zhang R; Li J; Zhang B; Li J; Lyons MJ; Faraone SV; Tsuang MT
    Drug Alcohol Depend; 2007 Oct; 90(2-3):159-65. PubMed ID: 17416470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
    Yu Z; Wen L; Shen X; Zhang H
    Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Influence of OPRM1 A118G Polymorphism on the Dosage of Morphine in Patients with Advanced Liver Cancer.
    Cheng H; Chu X; Yi S
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1375-1377. PubMed ID: 34689504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.